Radiolabeled MET binding proteins for immuno-PET imaging and methods of use thereof
US11896682B2 · kind B2 · utility
0Cited by
106References
47Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 15, 2020 |
| Grant date | Feb 13, 2024 |
| Priority date | — |
| Expiry date | Oct 29, 2041 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/71
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Radiolabeled anti-MET antibodies and MET×MET bispecific antibodies and their use in immuno-PET imaging are provided herein. Included are methods of detecting the presence of MET proteins in a subject or sample and methods of monitoring efficacy of treatment of a Met expressing tumor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.